s6y
Company name or ticker
Search
Axsome Therapeutics, Inc.
DEF 14A
Definitive proxy statements
Filed
Tuesday, April 21, 2020
Period
Jun 5, 2020
Accession number
0001140361-20-009379
Documents
Definitive proxy statements
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header